<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2018-01-17" updated="2019-12-02">
  <drugbank-id primary="true">DB13960</drugbank-id>
  <name>Bronopol</name>
  <description>Bronopol, or 2-Bromo-2-nitro-1,3-propanediol, is an organic compound with wide-spectrum antimicrobial properties. First synthesized in 1897, bronopol was primarily used as a preservative for pharmaceuticals and was registered in the United States in 1984 for use in industrial bactericides, slimicides and preservatives [F13]. Bronopol is used as a microbicide or microbiostat in various commercial and industrial applications, including oil field systems, air washer systems, air conditioning or humidifying systems, cooling water systems, papermills, absorbent clays, metal working fluids, printing inks, paints, adhesives and consumer products [F13]. Compared to other aliphatic halogen-nitro compounds, bronopol is more stable to hydrolysis in aqueous media under normal conditions [A32792]. The inhibitory activity against various bacteria, including _Pseudomonas aeruginosa_, was demonstrated _in vitro_ [A32792]. The agent is largely available commercially as an antibacterial for a variety of industrial purposes while it is predominantly available for purchase as a pet animal litter antibacterial at the domestic consumer level [F2317]. Nevertheless, ongoing contemporary re-evaluations of bronopol use in large markets such as Canada now place various compositional and product restrictions on the use of the agent in cosmetic products [L873] and in other products where it may not primarily be used in the role of a non-medicinal preservative antimicrobial [L874].</description>
  <cas-number>52-51-7</cas-number>
  <unii>6PU1E16C9W</unii>
  <average-mass>199.988</average-mass>
  <monoisotopic-mass>198.948020332</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32790</ref-id>
        <pubmed-id>3075439</pubmed-id>
        <citation>Shepherd JA, Waigh RD, Gilbert P: Antibacterial action of 2-bromo-2-nitropropane-1,3-diol (bronopol). Antimicrob Agents Chemother. 1988 Nov;32(11):1693-8.</citation>
      </article>
      <article>
        <ref-id>A32791</ref-id>
        <pubmed-id>22153260</pubmed-id>
        <citation>Shinn AP, Picon-Camacho SM, Bron JE, Conway D, Yoon GH, Guo FC, Taylor NG: The anti-protozoal activity of bronopol on the key life-stages of Ichthyophthirius multifiliis Fouquet, 1876 (Ciliophora). Vet Parasitol. 2012 May 25;186(3-4):229-36. doi: 10.1016/j.vetpar.2011.11.025. Epub 2011 Nov 12.</citation>
      </article>
      <article>
        <ref-id>A32792</ref-id>
        <pubmed-id>14265925</pubmed-id>
        <citation>CROSHAW B, GROVES MJ, LESSEL B: SOME PROPERTIES OF BRONOPOL, A NEW ANTIMICROBIAL AGENT ACTIVE AGAINST PSEUDOMONAS AERUGINOSA. J Pharm Pharmacol. 1964 Dec;16:SUPPL:127-30T.</citation>
      </article>
      <article>
        <ref-id>A32793</ref-id>
        <pubmed-id>12062701</pubmed-id>
        <citation>Wang H, Provan GJ, Helliwell K: Determination of bronopol and its degradation products by HPLC. J Pharm Biomed Anal. 2002 Jun 20;29(1-2):387-92.</citation>
      </article>
      <article>
        <ref-id>A32797</ref-id>
        <pubmed-id>7414618</pubmed-id>
        <citation>Buttar HS, Downie RH: The biotransformation and disposition of bronopol following topical and intravenous administration to rats. Toxicol Lett. 1980 Jul;6(2):101-7.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2578</ref-id>
        <title>BRONOPOL - National Library of Medicine HSDB Database</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7195</url>
      </link>
      <link>
        <ref-id>L4873</ref-id>
        <title>Health Canada Cosmetic Ingredient Hotlist of Prohibited and/or Restricted Ingredients</title>
        <url>https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients/hotlist.html#b1</url>
      </link>
      <link>
        <ref-id>L4874</ref-id>
        <title>Health Canada Drug and Health Products Chemical Substance: Bronopol Profile</title>
        <url>http://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=846&amp;lang=eng</url>
      </link>
    </links>
    <attachments>
      <attachment>
        <ref-id>F13</ref-id>
        <title>United States Environmental Protection Agency (EPA): Bronopol R.E.D. Facts Sheet</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/013/original/fs_PC-216400_1-Oct-95.pdf?1525106735</url>
      </attachment>
      <attachment>
        <ref-id>F14</ref-id>
        <title>The activity and safety of the antimicrobial agent Bronopol (2-bromo-2-nitropropan-1, 3-diol)</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/014/original/10.1.1.562.6397.pdf?1525109761</url>
      </attachment>
      <attachment>
        <ref-id>F2317</ref-id>
        <title>Canadian Pest Management Regulatory Agency Re-evaluation of Bronopol</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/317/original/H113-18-2005-6E.pdf?1545069110</url>
      </attachment>
    </attachments>
  </general-references>
  <synthesis-reference/>
  <indication>Bronopol as an active ingredient is registered as a commercial biocide and preservative in many industrial processes. Registered biocidal uses include pulp and paper mills, water cooling towers, waste water treatment, evaporative condensers, heat exchangers, food pasteurizing plants, metalworking fluids, and oilfield applications [F2317]. In addition, preservative uses include household products (e.g., dishwashing liquids, laundry products), latex emulsions, polymer lattices, pigments, leather and milk samples for analysis [F2317]. Bronopol is also formulated into granular domestic end-use products in the form of cat litter [F2317].</indication>
  <pharmacodynamics>At concentrations of 12.5 to 50 Î¼g/mL, bronopol mediated an inhibitory activity against various strains of Gram negative and positive bacteria _in vitro_ [A32792]. The bactericidal activity is reported to be greater against Gram-negative bacteria than against Gram-positive cocci [A32792]. Bronopol was also demonstrated to be effective against various fungal species, but the inhibitory action is reported to be minimal compared to that of against bacterial species [A32792]. The inhibitory activity of bronopol decreases with increasing pH of the media [A32792, F13]. Bronopol also elicits an anti-protozoal activity, as demonstrated with _Ichthyophthirius multifiliis_ _in vitro_ and _in vivo_ [A32791]. It is proposed that bronopol affects the survival of all free-living stages of _I. multifiliis_ [A32791]. </pharmacodynamics>
  <mechanism-of-action>It is proposed that bronopol generates biocide-induced bacteriostasis followed by a growth at an inhibited rate in bacteria, via two distinct reactions between bronopol and essential thiols within the bacterial cell [A32790]. Under aerobic conditions, bronopol catalyzes the oxidation of thiol groups, such as cysteine, to disulfides. This reaction is accompanied by rapid consumption of oxygen, where oxygen acts as the final oxidant. During the conversion of cysteine to cystine, radical anion intermediates such as superoxide and peroxide are formed from bronopol to exert a direct bactericidal activity. The oxidation of excess thiols alters the redox state to create anoxic conditions, leading to a second reaction involving the oxidation of intracellular thiols such as glutathione to its disulfide. The resulting effects are inhibition of enzyme function, and reduced growth rate following the bacteriostatic period [A32790]. Under the anoxic conditions, the reaction between thiol and bronopol decelerates without the involvement of oxygen and the consumption of bronopol predominates. Bronopol is ultimately removed from the reaction via consumption and resumption of bacterial growth occurs [A32790]. </mechanism-of-action>
  <toxicity>Oral LD50, dermal LD50, and inhalation LD50 in rat are 180 mg/kg [MSDS], 64-160 mg/kg [L2578], and &gt; 5000 mg/m^3 [MSDS] , respectively. In a 90-day dermal toxicity study in rabbits, the NOEL for systemic toxicity was 2 mg/kg/day [F13]. In a rat 90-day oral toxicity study, bronopol was associated with a severe gastrointestinal irritation [F13]. A chronic feeding or carcinogenicity study with rats resulted in high mortality, stomach lesions, and severe reduction in body weight gain. A reduction in weight gain was also observed in a chronic dermal or carcinogenicity study of mice [F13]. Bronopol was not mutagenic in four mutagenicity studies [F13]. </toxicity>
  <metabolism>Bronopol undergoes degradation in aqueous medium to form bromonitroethanol from a retroaldol reaction with the liberation of an equimolar amount of formaldehyde [A32793]. Formaldehyde is a degradation product of bronopol, which may cause sensitization [L2578]. Bromonitroethanol further decomposes to formaldehyde and bromonitromethane. Bromonitroethanol may also break down to release a nitrite ion and 2-bromoethanol [A32793]. </metabolism>
  <absorption>Bronopol was rapidly absorbed in animal studies. It may be absorbed via aerosol inhalation, dermal contact, and ingestion [L2578]. In rats, approximately 40% of the topically applied dose of bronopol was absorbed through the skin within 24 hr [L2578]. Following oral administration of 1 mg/kg in rats, the peak plasma concentrations of bronopol were reached up to 2 hours post-dosing [A32797].</absorption>
  <half-life>The half-life of bronopol in the biological systems is not reported in the literature. The half-life value reported for bronopol reflects the environment fate of the compound. When released into the air as vapours, bronopol is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals where the half life for this reaction is approximately 11 days [L2578]. The photolysis half-life is 24 hours in water but may be up to 2 days under natural sunlight [L2578]. </half-life>
  <protein-binding>No data available. </protein-binding>
  <route-of-elimination>Metabolism studies indicate that bronopol is primarily excreted in the urine [F13]. In rats, about 19% of dermally-applied bronopol was excreted in the urine, feces and expired air [L2578]. Following oral administration of 1 mg/kg radiolabelled bronopol in rats, approximately 81% and 6% of the administered radioactivity was recovered in the urine and expired air, respectively, within a period of 24 hours [A32797]. Following intravenous administration in rat, the recoveries in the urine and expired air were 74% and 9% of the dose, respectively [A32797]. </route-of-elimination>
  <volume-of-distribution>The highest concentrations of bronopol were detected in the excretory organs of rat such as kidney, liver, and lung [A32797]. The lowest concentration was in the fat [A32797].</volume-of-distribution>
  <clearance>No data available. </clearance>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">2-Bromo-2-nitropropane-1,3-diol</synonym>
    <synonym language="english" coder="">2-Nitro-2-bromo-1,3-propanediol</synonym>
    <synonym language="english" coder="">beta-Bromo-beta-nitrotrimethyleneglycol</synonym>
    <synonym language="english" coder="inn">Bronopol</synonym>
    <synonym language="polish" coder="">Bronopolu</synonym>
    <synonym language="latin" coder="">Bronopolum</synonym>
  </synonyms>
  <products>
    <product>
      <name>Antiseptic Hand Soap</name>
      <labeller>Dustbane Products Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00564311</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Michaels Antiseptic Hand Soap</name>
      <labeller>Michael's Equipment (Ottawa) Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00590231</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1999-07-05</ended-marketing-on>
      <dosage-form>Soap</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>T.R.U.E. Test Thin-Layer Rapid Use Patch Test</name>
      <labeller>SmartPractice Denmark ApS</labeller>
      <ndc-id/>
      <ndc-product-code>67334-0457</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Cutaneous</route>
      <fda-application-number>BLA103738</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>T.R.U.E. Test Thin-Layer Rapid Use Patch Test</name>
      <ingredients>2-mercaptobenzothiazole + 2,2'-Dibenzothiazyl disulfide + 4-(Isopropylamino)diphenylamine + alpha-Amyl cinnamaldehyde + Bacitracin + Balsam of Peru + Benzocaine + Benzylparaben + Bisphenol A diglycidyl ether + Bromothalonil + Bronopol + Budesonide + Butylparaben + Chlorquinaldol + Cinchocaine + Cinnamaldehyde + Cinnamyl alcohol + Clioquinol + Cobalt chloride + Diazolidinylurea + Dichromate + Dipentamethylenethiuram disulfide + Diphenylguanidine + Disperse Blue 106 + Disulfiram + Ditiocarb Zinc + Ethyl hydroxybenzoate + Ethylenediamine + Eugenol + Evernia prunastri + Formaldehyde + Geraniol + Hydrocortisone butyrate + Hydroxycitronellal + Imidurea + Isoeugenol + Lanolin alcohols + Methylchloroisothiazolinone + Methylparaben + Morpholinylmercaptobenzothiazole + N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine + N,N'-diphenyl-1,4-phenylenediamine + Neomycin + Nickel sulfate + p-Phenylenediamine + P-Tert-Butylphenol-Formaldehyde Resin (Low Molecular Weight) + Parthenolide + Propylparaben + Quaternium-15 + Rosin + Sodium aurotiosulfate + Tetracaine + Tetramethylthiuram monosulfide + Thimerosal + Thiohexam + Thiram + Tixocortol + Zinc Dibutyldithiocarbamate</ingredients>
    </mixture>
    <mixture>
      <name>Michaels Antiseptic Hand Soap</name>
      <ingredients>Bronopol + Triclosan</ingredients>
    </mixture>
    <mixture>
      <name>Antiseptic Hand Soap</name>
      <ingredients>Bronopol + Triclosan</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Alcohols</category>
      <mesh-id>D000438</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents, Local</category>
      <mesh-id>D000891</mesh-id>
    </category>
    <category>
      <category>Cell-mediated Immunity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Drugs that are Mainly Renally Excreted</category>
      <mesh-id/>
    </category>
    <category>
      <category>Glycols</category>
      <mesh-id>D006018</mesh-id>
    </category>
    <category>
      <category>Increased Histamine Release</category>
      <mesh-id/>
    </category>
    <category>
      <category>Indicators and Reagents</category>
      <mesh-id>D007202</mesh-id>
    </category>
    <category>
      <category>Laboratory Chemicals</category>
      <mesh-id>D019995</mesh-id>
    </category>
    <category>
      <category>Preservatives, Pharmaceutical</category>
      <mesh-id>D011310</mesh-id>
    </category>
    <category>
      <category>Standardized Chemical Allergen</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Yeast and other fungi</affected-organism>
    <affected-organism>Gram negative and gram positive bacteria</affected-organism>
    <affected-organism>Pseudomonas aeruginosa</affected-organism>
    <affected-organism>Streptococcus pyogenes</affected-organism>
    <affected-organism>Escherichia coli</affected-organism>
    <affected-organism>Staphylococcus aureus</affected-organism>
    <affected-organism>Proteus vulgaris</affected-organism>
    <affected-organism>Shigella</affected-organism>
    <affected-organism>Proteus mirabilis</affected-organism>
    <affected-organism>Klebsiella pneumoniae</affected-organism>
    <affected-organism>Enterobacter aerogenes</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Soap</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Cutaneous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB13960.pdf?1525105430</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.21</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-1.2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.28e+01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.19</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>2-bromo-2-nitropropane-1,3-diol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>bronopol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>199.988</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>198.948020332</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OCC(Br)(CO)[N+]([O-])=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C3H6BrNO4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C3H6BrNO4/c4-3(1-6,2-7)5(8)9/h6-7H,1-2H2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>LVDKZNITIUWNER-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>83.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>31.66</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>13.17</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>12.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-3.7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>25-25g/100mL at 22Â°C</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>123-130</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>130</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.6</value>
      <source>MSDS</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>3975</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>31306</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C13034</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D01577</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>2356</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Bronopol</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1408862</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB13960</drugbank-id>
        <name>Bronopol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET00531</drugbank-id>
        <name>Formaldehyde</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB13960</drugbank-id>
        <name>Bronopol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02073</drugbank-id>
        <name>Bromonitroethanol</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DBMET02073</drugbank-id>
        <name>Bromonitroethanol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET00531</drugbank-id>
        <name>Formaldehyde</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DBMET02073</drugbank-id>
        <name>Bromonitroethanol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02074</drugbank-id>
        <name>Bromonitromethane</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DBMET02073</drugbank-id>
        <name>Bromonitroethanol</name>
      </left-element>
      <right-element>
        <drugbank-id>DB12529</drugbank-id>
        <name>Nitrite</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DBMET02073</drugbank-id>
        <name>Bromonitroethanol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02075</drugbank-id>
        <name>2-bromoethanol</name>
      </right-element>
      <enzymes/>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0009370</id>
      <name>Thiol groups</name>
      <organism>Humans</organism>
      <actions>
        <action>oxidizer</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A32790</ref-id>
            <pubmed-id>3075439</pubmed-id>
            <citation>Shepherd JA, Waigh RD, Gilbert P: Antibacterial action of 2-bromo-2-nitropropane-1,3-diol (bronopol). Antimicrob Agents Chemother. 1988 Nov;32(11):1693-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>